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Background
The clinical identification of inflammatory asthma pheno-
types currently requires sputum analysis. Sputum analysis
has proven its value in diagnosis and disease monitoring.
However, technical limitations hamper its implementation
in daily clinical practice. There is a strong need for fast,
non-invasive and accurate diagnostic methods to pheno-
type and monitor asthma.
Objective
To assess whether Nonlinear Principal Component Ana-
lysis (NLPCA) of peripheral blood characteristics and
clinical parameters can identify inflammatory pheno-
types in asthma without the need for sputum analysis.
Method
Clinical parameters, activation of blood granulocytes and
sputum phenotypes were assessed in 115 adult asthma
patients (NCT01611012). Blood granulocytes were
stained with antibodies against the active FcgRII recep-
tor (CD32, clones A17/A27) and a-chain of MAC-1
(CD11b) in the presence or absence of fMLF, and ana-
lysed by flow cytometry. NLPCA was used to reduce
dimensions in a combined cellular and clinical dataset,
followed by discriminant analysis to generate a predic-
tion model. Phenotypes identified by the model were
cross-validated by inflammatory sputum phenotypes
based on sputum induction (reference test).
Results
Peripheral blood eosinophil count, FeNO (Fraction of
Exhaled Nitric Oxide), ACQ (Asthma Control Question-
naire), medication use, nasal polyposis, aspirin sensitivity
and neutrophil/eosinophil responsiveness upon stimula-
tion, are important parameters to differentiate between
eosinophilic and non-eosinophilic phenotypes. The combi-
nations of these parameters lead to an accurate prediction
model for eosinophilic asthma with 90.5% sensitivity and
91.5% specificity.
Conclusion
The proposed prediction model identifies eosinophilic
asthma by using peripheral blood analysis, FeNO and
routine clinical data, resulting in a reliable non-invasive
test that is adequate for daily clinical practice.
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